Precede Biosciences

Developer of a liquid biopsy platform designed to provide unprecedented resolution into disease-defining biology from a simple blood test. The company's platform profiles circulating chromatin and the...

Healthcare
Boston, MA, United States
Founded 2021
48 employees
Website
Valuation
$210M
Market implied
Share Price
N/A
Total Raised
$132M
Last Round
N/A

Get the full picture

Create a free account to unlock Precede Biosciences's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required